145 related articles for article (PubMed ID: 1740355)
1. The effects of complement depletion on corneal inflammation in rats.
Verhagen C; Breebaart AC; Kijlstra A
Invest Ophthalmol Vis Sci; 1992 Feb; 33(2):273-9. PubMed ID: 1740355
[TBL] [Abstract][Full Text] [Related]
2. The effect of systemic decomplementation with cobra venom factor on corneal complement levels in guinea pigs.
Pleyer U; Mondino BJ; Sumner HL
Invest Ophthalmol Vis Sci; 1992 Jun; 33(7):2212-5. PubMed ID: 1607231
[TBL] [Abstract][Full Text] [Related]
3. Pre-treatment of donor with 1-deamino-8-d-arginine vasopressin could alleviate early failure of porcine xenograft in a cobra venom factor treated canine recipient.
Kang HJ; Lee G; Kim JY; Lee SH; Wi HC; Hwang PG; Chung DH; Kim YT
Eur J Cardiothorac Surg; 2005 Jul; 28(1):149-56. PubMed ID: 15982598
[TBL] [Abstract][Full Text] [Related]
4. Analysis of corneal inflammation following the injection of heterologous serum into the rat cornea.
Verhagen C; Den Heijer R; Broersma L; Breebaart AC; Kijlstra A
Invest Ophthalmol Vis Sci; 1991 Dec; 32(13):3238-44. PubMed ID: 1836205
[TBL] [Abstract][Full Text] [Related]
5. Complement dependence of antibody-induced mesangial cell injury in the rat.
Yamamoto T; Wilson CB
J Immunol; 1987 Jun; 138(11):3758-65. PubMed ID: 3495569
[TBL] [Abstract][Full Text] [Related]
6. Complement depletion with humanised cobra venom factor: efficacy in preclinical models of vascular diseases.
Vogel CW; Fritzinger DC; Gorsuch WB; Stahl GL
Thromb Haemost; 2015 Mar; 113(3):548-52. PubMed ID: 25031089
[TBL] [Abstract][Full Text] [Related]
7. Complement activation is critical to airway hyperresponsiveness after acute ozone exposure.
Park JW; Taube C; Joetham A; Takeda K; Kodama T; Dakhama A; McConville G; Allen CB; Sfyroera G; Shultz LD; Lambris JD; Giclas PC; Holers VM; Gelfand EW
Am J Respir Crit Care Med; 2004 Mar; 169(6):726-32. PubMed ID: 14701711
[TBL] [Abstract][Full Text] [Related]
8. Enhancement of antigen-induced bronchoconstriction after intravascular complement activation with cobra venom factor. Reversal by granulocyte depletion.
Regal JF; Fraser DG; Anderson DE; Solem LE
J Immunol; 1993 Apr; 150(8 Pt 1):3496-505. PubMed ID: 8468484
[TBL] [Abstract][Full Text] [Related]
9. Complement depletion aggravates Staphylococcus aureus septicaemia and septic arthritis.
Sakiniene E; Bremell T; Tarkowski A
Clin Exp Immunol; 1999 Jan; 115(1):95-102. PubMed ID: 9933426
[TBL] [Abstract][Full Text] [Related]
10. Thermal response to zymosan: the differential role of complement.
Li S; Llanos-Q J; Blatteis C
Neuroimmunomodulation; 2002-2003; 10(2):122-8. PubMed ID: 12372985
[TBL] [Abstract][Full Text] [Related]
11. Lipopolysaccharide-induced pulmonary vascular sequestration of polymorphonuclear leukocytes is complement independent.
Cardozo C; Edelman J; Jagirdar J; Lesser M
Am Rev Respir Dis; 1991 Jul; 144(1):173-8. PubMed ID: 2064126
[TBL] [Abstract][Full Text] [Related]
12. Complement depletion with cobra venom factor delays acute cell-mediated rejection in pig-to-mouse corneal xenotransplantation.
Oh JY; Kim MK; Lee HJ; Ko JH; Kim Y; Park CS; Kang HJ; Park CG; Kim SJ; Lee JH; Wee WR
Xenotransplantation; 2010; 17(2):140-6. PubMed ID: 20522246
[TBL] [Abstract][Full Text] [Related]
13. Relation between complement and the febrile response of guinea pigs to systemic endotoxin.
Li S; Sehic E; Wang Y; Ungar AL; Blatteis CM
Am J Physiol; 1999 Dec; 277(6):R1635-45. PubMed ID: 10600909
[TBL] [Abstract][Full Text] [Related]
14. Functional analysis of Cobra Venom Factor/human C3 chimeras transiently expressed in mammalian cells.
Kölln J; Matzas M; Jänner N; Mix T; Klensang K; Bredehorst R; Spillner E
Mol Immunol; 2004 May; 41(1):19-28. PubMed ID: 15140572
[TBL] [Abstract][Full Text] [Related]
15. The role of complement activation in tumour necrosis factor-induced lethal hepatitis.
Libert C; Wielockx B; Grijalba B; Van Molle W; Kremmer E; Colten HR; Fiers W; Brouckaert P
Cytokine; 1999 Aug; 11(8):617-25. PubMed ID: 10433810
[TBL] [Abstract][Full Text] [Related]
16. Effect of complement consumption by cobra venom factor on the course of primary infection with simian immunodeficiency virus in rhesus monkeys.
Schmitz JE; Lifton MA; Reimann KA; Montefiori DC; Shen L; Racz P; Tenner-Racz K; Ollert MW; Forman MA; Gelman RS; Vogel CW; Letvin NL
AIDS Res Hum Retroviruses; 1999 Jan; 15(2):195-202. PubMed ID: 10029251
[TBL] [Abstract][Full Text] [Related]
17. Effects of treatment with cobra venom factor on experimentally induced feline leukemia.
Kraut EH; Rojko JL; Olsen RG; Tuomari DL
Am J Vet Res; 1987 Jul; 48(7):1063-6. PubMed ID: 2820273
[TBL] [Abstract][Full Text] [Related]
18. Effects of decomplementation with cobra venom factor on experimental vasculitis.
Mathieson PW; Qasim FJ; Thiru S; Oldroyd RG; Oliveira DB
Clin Exp Immunol; 1994 Sep; 97(3):474-7. PubMed ID: 8082302
[TBL] [Abstract][Full Text] [Related]
19. A monoclonal antibody-cobra venom factor conjugate increases the tumor-specific uptake of a 99mTc-labeled anti-carcinoembryonic antigen antibody by a two-step approach.
Juhl H; Sievers M; Baltzer K; Helmig F; Wolf H; Brenner W; Kalthoff H
Cancer Res; 1995 Dec; 55(23 Suppl):5749s-5755s. PubMed ID: 7493340
[TBL] [Abstract][Full Text] [Related]
20. Systemic complement depletion reduces inflammation and demyelination in adoptive transfer experimental allergic neuritis.
Vriesendorp FJ; Flynn RE; Malone MR; Pappolla MA
Acta Neuropathol; 1998 Mar; 95(3):297-301. PubMed ID: 9542596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
